Top Story

Future ‘very bright’ in acute myeloid leukemia

March 23, 2019
In the Journals

Inflammatory markers linked to neurotoxicity severity after CAR T-cell infusion for DLBCL

March 20, 2019
Neurotoxicity from chimeric antigen receptor T-cell therapy appeared associated with cytokine release syndrome, with blood levels of cytokines and other inflammatory…
In the Journals

Survival rates after HSCT have not improved among infants with malignant diseases

March 18, 2019
Infants with malignant diseases who underwent allogeneic hematopoietic stem cell transplantation did not demonstrate improved survival rates over a 15-year period…
In the Journals

Lenalidomide, azacitidine regimen safe, active in relapsed AML after transplant

March 17, 2019
The combination of lenalidomide and azacitidine appeared safe and demonstrated clinical activity in patients with relapsed acute myeloid leukemia or myelodysplastic…
More Headlines »

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

This activity is supported by an educational grant from Pharmacyclics LLC.

Therapeutic options continue to expand for patients with hematologic malignancies. The clinical evaluation of novel…
More »
Meeting News

VIDEO: Trials explore optimal treatments, resistance in chronic lymphocytic leukemia

January 18, 2019
More »
Resource Centers
Discoveries from ASH Leukemia

Discoveries from ASH Leukemia


Ace the Case: A 71-Year-Old Man Who Presents With Complaints of Fatigue and Easy Bruisability

There is no commercial support for this activity.

This educational activity will discuss the diagnosis and management of a 71-year-old male who presents to his primary…
More »